Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-5-8
pubmed:abstractText
Insulin-like growth factor-I (IGF-I), transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) induced cathepsin D gene expression and reporter gene activity in MCF-7 human breast cancer cells transiently transfected with a construct (pCD1) containing a -2576 to -124 cathepsin D gene promoter insert. In contrast, IGF-I, but not TGFalpha or EGF, induced reporter gene activity in cells cotransfected with wild-type estrogen receptor (ER) expression plasmid and a construct (pCD2) containing estrogen-responsive downstream elements from -208 to -101. Promoter deletion and mutational analysis experiments identified four GC-rich sites and an imperfect palindromic estrogen responsive element required for IGF-I activation of the ER (ligand-independent). Subsequent studies with the mitogen-activated protein kinase (MAPK) inhibitor, PD98059, and a serine(118(-ER mutant confirmed the role of the MAPK pathway for IGF-I activation of the ER in MCF-7 cells. Thus, growth factor activation of ER can mediate transactivation vs ER/Sp1 binding to GC-rich sites and represents a novel pathway for ligand-independent ER action. The divergent pathways for IGF-I and TGFalpha/EGF activation of the ER observed in MCF-7 cells contrast with previous data indicating that pathways for growth factor activation of the ER are dependent on the gene and/or gene promoter and on cell context.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0952-5041
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
193-202
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10750020-Base Sequence, pubmed-meshheading:10750020-Breast Neoplasms, pubmed-meshheading:10750020-Cathepsin D, pubmed-meshheading:10750020-Cell Division, pubmed-meshheading:10750020-Epidermal Growth Factor, pubmed-meshheading:10750020-Female, pubmed-meshheading:10750020-Gene Expression Regulation, Enzymologic, pubmed-meshheading:10750020-Genes, Reporter, pubmed-meshheading:10750020-Growth Substances, pubmed-meshheading:10750020-Humans, pubmed-meshheading:10750020-Insulin-Like Growth Factor I, pubmed-meshheading:10750020-Molecular Sequence Data, pubmed-meshheading:10750020-Plasmids, pubmed-meshheading:10750020-Promoter Regions, Genetic, pubmed-meshheading:10750020-Receptors, Estrogen, pubmed-meshheading:10750020-Sequence Deletion, pubmed-meshheading:10750020-Transcriptional Activation, pubmed-meshheading:10750020-Transfection, pubmed-meshheading:10750020-Transforming Growth Factor alpha, pubmed-meshheading:10750020-Tumor Cells, Cultured
pubmed:year
2000
pubmed:articleTitle
Transcriptional activation of cathepsin D gene expression by growth factors.
pubmed:affiliation
Department of Veterinary Physiology, Texas A & M University, College Station, Texas 77843-4466, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't